NasdaqGS:SHCLife Sciences
Assessing Sotera Health (SHC) Valuation After Earnings Beat And Upgraded Analyst Optimism
Sotera Health (SHC) has attracted fresh attention after reporting fourth quarter net revenues of US$1.16b, up 5.7% year over year. The results beat consensus estimates and lifted earnings expectations among brokerage firms.
See our latest analysis for Sotera Health.
The strong fourth quarter update has come alongside a sharp shift in sentiment, with a 1-day share price return of 3.70% and 7-day share price return of 8.54% contrasting with a 90-day share price return decline of 15.70%...